Clinical Trials Browser

Phase 1 × Carcinoma, Ovarian Epithelial × spartalizumab × Clear all

NCT03294694 2025-05-31

Ribociclib + PDR001 in Breast Cancer and Ovarian Cancer

Phase 1 Terminated

BreastGynecologic

Carcinoma, Ovarian Epithelial, Breast Neoplasms